Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Nature|August 16, 2013
lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programsLiuqing Yang, Chunru Lin, Chunyu Jin, et al.
Pharmacological Research|February 11, 2023
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived modelsPengfei Xu, Joy C Yang, Shu Ning, et al.
Cancers|October 16, 2025
Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate CancerPengfei Xu, Huan Qu, Joy C Yang, et al.
Cell Reports|September 15, 2016
KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and GlycolysisLing-Yu Wang, Chiu-Lien Hung, Yun-Ru Chen, et al.
Oncogene|June 14, 2024
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancerBo Chen, Pengfei Xu, Joy C Yang, et al.
Molecular Cancer Therapeutics|August 5, 2022
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide TreatmentShu Ning, Chengfei Liu, Wei Lou, et al.
International Journal of Molecular Sciences|July 15, 2026
Glutamate Ionotropic Kainate Receptors as Therapeutic Targets in Enzalutamide-Resistant and Neuroendocrine Prostate CancerHuan Qu, Pengfei Xu, Joy C Yang, et al.
Cancer Research|November 18, 2015
miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and SrcXu-Bao Shi, Ai-Hong Ma, Lingru Xue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate CancerCameron M Armstrong, Chengfei Liu, Liangren Liu, et al.
Oncogene|July 17, 2021
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signalingChengfei Liu, Cameron M Armstrong, Shu Ning, et al.
Pageof 4